微信公众号

官网二维码

中国癌症防治杂志 ›› 2025, Vol. 17 ›› Issue (5): 541-547.doi: 10.3969/j.issn.1674-5671.202c

• 肿瘤心脏病诊疗专栏 • 上一篇    下一篇

肾癌合并心力衰竭患者围术期安全管理策略与临床结局分析

  

  1. 首都医科大学附属北京安贞医院泌尿外科;国家心血管疾病临床医学研究中心;首都医科大学附属北京安贞医院心内科;首都医科大学附属北京安贞医院麻醉科
  • 出版日期:2025-10-25 发布日期:2025-12-03
  • 通讯作者: 张宁 E-mail:niru7429@126.com
  • 基金资助:
    首都医科大学附属北京安贞医院高水平研究专项(2024AZC3001);北京医学奖励基金会课题项目(YXJL?2021?0002?0768)

Perioperative safety management strategies and clinical outcomes in patients with renal cell carcinoma complicated by heart failure


  • Online:2025-10-25 Published:2025-12-03

摘要: 目的 初步探索肾癌合并心力衰竭患者的围术期安全管理策略。方法 回顾性分析2023年3月至2025年3月首都医科大学附属北京安贞医院肾癌合并心力衰竭并接受手术患者的临床资料,包括患者基线信息、心功能相关指标、手术相关数据、围术期管理策略及院内并发症,并通过电话随访预后信息。采用非参数Wilcoxon秩和检验及Kruskal⁃Wallis检验比较非正态分布数据组间差异,采用Wilcoxon 符号秩检验比较术前与术后B型利钠肽(B⁃type natriuretic peptide,BNP)差异,并通过多重线性回归模型分析连续变量间的相关性,以明确基线信息及围术期变量对该类患者安全性的影响。 结果 纳入20例患者,其中男性18例、女性2例,术前美国纽约心脏病学会(New York Heart Association,NYHA)心功能分级Ⅱ级2例、Ⅲ级15例、Ⅳ级3例,左心室射血分数(left ventricular ejection fraction,LVEF)≤30% 5例、30%<LVEF≤40%  8例、40%<LVEF≤49%  4例、LVEF≥50% 3例,根治性肾切除18例、肾部分切除2例,手术时间100.00 (88.75,110.00) min,术中出血量20.00 (10.00, 50.00) mL。术后1 d的BNP水平高于术前[274.00 (204.25~393.50) pg/mL vs 94.00 (50.00~229.50) pg/mL,P=0.004]。术后30 d内发生并发症2例,其中急性心肌梗死1例,应激性胃溃疡1例,均未发生急性失代偿性心力衰竭事件。中位随访时间为18.5(4.0~28.0)个月,19例存活,1例发生肿瘤远处转移并死亡。术后NYHA心功能分级较术前显著改善,其中6例改善2级,10例改善1级,2例未发生改变,1例恶化1级。结论 NYHAⅡ~Ⅳ级(25%≤LVEF≤60%)肾癌患者通过术前充分评估和药物治疗调整、术中麻醉优化管理、术后密切监测与疼痛处理后,行肾脏切除手术安全可行,围术期未发生急性失代偿性心力衰竭事件,术后心功能得到改善,提示肾癌合并心力衰竭的患者可在安全管理策略下行手术治疗。

关键词: 肾癌, 心力衰竭, 左心室射血分数, 围术期管理

Abstract: Objective To preliminarily explore perioperative safety management strategies for patients with renal cell carcinoma (RCC) complicated by heart failure (HF). Methods The clinical data from patients with RCC complicated by HF who underwent surgery at Beijing Anzhen Hospital, Capital Medical University, from March 2023 to March 2025 were retrospectively analyzed. The clinical data included baseline characteristics, cardiac functional parameters, operative variables, perioperative management strategies, in⁃hospital complications, and postoperative outcomes, which were obtained through telephone follow⁃up. For statistical analysis, the Wilcoxon rank⁃sum test and Kruskal⁃Wallis test were used to compare non⁃normally distributed data across different groups, while the Wilcoxon signed⁃rank test was used to assess changes in B⁃type natriuretic peptide (BNP) levels pre⁃ and postoperative. Multivariable linear regression was performed to analyze correlations among continuous variables to identify baseline or perioperative factors influencing safety outcomes. Results Twenty patients were enrolled, comprising 18 males and 2 females. According to New York Heart Association(NYHA) classification, gradeⅡ in 2, grade Ⅲ in 15, and gradeⅣin 3 patients. The left ventricular ejection fraction (LVEF) was ≤30% in 5, 30%<LVEF≤40% in 8, 40%<LVEF≤49% in 4, and LVEF≥50% in 3 patients. Radical nephrectomy was performed in 18 patients, while partial nephrectomy in 2 patients. The median operative time was 100.00 (88.75, 110.00) mins, and the median intraoperative blood loss was 20.00 (10.00, 50.00) mL. Postoperative day⁃1 BNP levels were significantly higher than preoperative levels [274.00 (204.25-393.50) pg/mL vs 94.00 (50.00-229.50) pg/mL, P=0.004]. Two perioperative complications occurred within 30 d, including one acute myocardial infarction and one stress⁃related gastric ulcer, and no episodes of acute decompensated HF were observed. The median follow⁃up duration was 18.5 (4.0-28.0) months. Nineteen patients survived, while one patient died due to distant tumor metastasis. NYHA functional class improved by 2 levels in 6 patients, by 1 level in 10 patients, remained unchanged in 2 patients, and worsened by 1 level in 1 patient, demonstrating a significant improvement in postoperative cardiac function compared with preoperative status. Conclusions Nephrectomy is safe and feasible for RCC patients with NYHA class Ⅱ-Ⅳ HF (LVEF 25%-60%) when preceded by comprehensive preoperative evaluation and medical adjustment, optimized intraoperative anesthetic management, and vigilant postoperative monitoring and pain control. No perioperative episodes of acute decompensated HF occurred, and postoperative cardiac function improved, suggesting that surgical treatment can be safely performed in RCC patients with HF under structured perioperative management strategies.

Key words: Renal cell carcinoma, Heart failure, Left ventricular ejection fraction, Perioperative management

中图分类号: 

  •